DAFNA Capital Management’s Reunion Neuroscience Inc. Common Shares REUN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-12,598
Closed -$8.7K 79
2023
Q1
$8.7K Sell
12,598
-35,081
-74% -$39.1K ﹤0.01% 72
2022
Q4
$42.9K Sell
47,679
-48,906
-51% -$71.3K 0.01% 78
2022
Q3
$138K Sell
96,585
-284,243
-75% -$1.01M 0.04% 85
2022
Q2
$1.6M Sell
380,828
-57,434
-13% -$287K 0.44% 52
2022
Q1
$2.94M Buy
438,262
+370,082
+543% +$3.08M 0.77% 36
2021
Q4
$839K Hold
68,180
0.21% 68
2021
Q3
$1.56M Buy
+68,180
New +$1.72M 0.42% 56

Other funds holding REUN

DAFNA Capital Management's REUN Position: Q2 2023 in Review

DAFNA Capital Management sold out of Reunion Neuroscience Inc. Common Shares (REUN) in Q2 2023, closing a stake of 12,598 shares — an estimated $8.7K sold.

DAFNA Capital Management first reported a position in REUN in Q3 2021 and held it in 7 quarters. The position peaked at $2.94M in Q1 2022. 21 funds tracked by Wall St. Rank hold REUN as of Q2 2023.

  • DAFNA Capital Management reported no remaining Reunion Neuroscience Inc. Common Shares position as of Q2 2023 after selling out during the quarter.
  • DAFNA Capital Management sold 12,598 Reunion Neuroscience Inc. Common Shares shares in Q2 2023, an estimated $8.7K.
  • DAFNA Capital Management first reported a position in Reunion Neuroscience Inc. Common Shares in Q3 2021 and held it in 7 quarters.
  • DAFNA Capital Management's Reunion Neuroscience Inc. Common Shares position peaked at $2.94M in Q1 2022.
  • 21 funds tracked by Wall St. Rank held Reunion Neuroscience Inc. Common Shares as of Q2 2023.

Based on DAFNA Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.